Law.com Subscribers SAVE 30%

Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.

<B><I>BREAKING NEWS:</b></i> <b>Merck Settles Vioxx Case for $950 Million</b>

Nate Raymond

Merck &amp; Co., Inc. became the latest healthcare company to strike a major settlement with the Justice Department on Nov. 22, agreeing to pay $950 million to resolve criminal and civil charges stemming from its marketing of the painkiller Vioxx.

Drug & Device News

ALM Staff & Law Journal Newsletters

News you may have missed.

Features

Verdicts

ALM Staff & Law Journal Newsletters

Analysis of recent key rulings.

Med Mal News

ALM Staff & Law Journal Newsletters

All the latest you need to know.

Features

Effective Use of Physician Assistants

Barry B. Cepelewicz & Richard J. Nealon

The use of P.A.s presents a number of medico-legal issues for a practice that must be considered, both by medical practitioners and their legal counsel. Failure to do so could result in increased liability exposure for the physician and the practice.

Features

Hospital-Acquired Infections Are on the Rise

Brandon Swartz

Last month, we discussed the rising incidence of deaths related to hospital-acquired infections. With the accompanying publicity of the dangers MRSA infection poses, it is not surprising that litigation in this area is also on the rise.

The Future of Medical Malpractice Claims in a 'Tele-World'

Elizabeth A. Syer

The pros and cons of "telemedicine," and what it means to the med mal practitioner.

Verdicts

ALM Staff & Law Journal Newsletters

In-depth analysis of an important ruling.

Features

Drug & Device News

ALM Staff & Law Journal Newsletters

Recent news of interest to you and your practice.

Med Mal News

ALM Staff & Law Journal Newsletters

A recent item of interest.

Need Help?

  1. Prefer an IP authenticated environment? Request a transition or call 800-756-8993.
  2. Need other assistance? email Customer Service or call 1-877-256-2472.

MOST POPULAR STORIES

  • Navigating the Attorney-Client Privilege and Work Product Doctrine in Bankruptcy
    When a company declares bankruptcy, avoidance actions under Chapter 5 of the Bankruptcy Code can assist in securing extra cash for the debtor's dwindling estate. When a debtor-in-possession does not pursue these claims, creditors' committees often seek the bankruptcy court's authorization to pursue them on behalf of the estate. Once granted such authorization through a “standing order,” a creditors' committee is said to “stand in the debtor's shoes” because it has permission to litigate certain claims belonging to the debtor that arose before bankruptcy. However, for parties whose cases advance to discovery, such a standing order may cause issues by leaving undecided the allocation of attorney-client privilege and work product protection between the debtor and committee.
    Read More ›